objectivesteroidinduc
hyperglycemia
common
hospit
patient
diabet
mellitu
guidelin
glucos
manag
set
lack
methodsw
conduct
retrospect
chart
review
noncrit
ill
patient
diabet
receiv
steroid
hospit
januari
octob
fiftyeight
patient
identifi
consult
multivari
linear
regress
use
assess
median
daili
insulin
requir
normoglycem
patient
compar
hyperglycem
patient
resultsof
total
patient
includ
studi
achiev
normoglycemia
admiss
patientday
weight
mean
blood
glucos
pdwmbg
level
mgdl
remain
hyperglycem
pdwmbg
level
mgdl
p
differ
patient
group
age
sex
race
bodi
weight
renal
function
hba
level
glucosealt
medic
diabet
type
diseas
durat
follow
multivari
adjust
compar
hyperglycem
patient
normoglycem
patient
requir
similar
unit
basal
insulin
median
interquartil
rang
vs
p
higher
unit
nutrit
insulin
vs
p
lower
unit
correct
insulin
vs
p
patient
achiev
normoglycemia
requir
significantli
lower
percentag
correct
insulin
total
daili
dose
tdd
vs
p
higher
percentag
nutrit
insulin
tdd
vs
p
hyperglycem
patient
differ
tdd
per
kilogram
tdd
per
milligram
hydrocortison
dose
tdd
per
milligram
hydrocortison
dose
per
kilogram
weight
group
data
suggest
noncrit
ill
patient
hyperglycemia
receiv
steroid
requir
higher
percentag
tdd
insulin
therapi
nutrit
insulin
achiev
normoglycemia
diabet
highli
preval
condit
unit
state
patient
admit
hospit
histori
diabet
mani
studi
suggest
hyperglycemia
hospit
patient
associ
poor
outcom
increas
mortal
increas
incid
infect
prolong
length
stay
glucocorticoid
commonli
prescrib
treatment
mani
inflammatori
allerg
immunolog
malign
disord
hyperglycemia
frequent
experienc
patient
steroid
administr
preval
among
patient
without
previou
histori
diabet
american
diabet
associ
ada
american
associ
clinic
endocrinologist
endocrin
societi
publish
guidelin
appropri
manag
patient
develop
hyperglycemia
secondari
steroid
therapi
howev
recommend
base
expert
opinion
rather
evidencebas
data
lack
area
recent
statement
ada
endocrin
societi
recommend
patient
treat
glucocorticoid
develop
hyperglycemia
treat
basalbolu
insulin
regimen
start
dose
unitskgday
notabl
endocrin
societi
ada
understand
magnitud
problem
recommend
use
continu
insulin
infus
patient
receiv
highdos
glucocorticoid
develop
sever
hyperglycemia
treatment
easili
implement
critic
careintens
care
unit
icu
set
noncrit
care
set
eg
gener
ward
inpati
glucos
manag
guidelin
subcutan
insulin
therapi
recommend
insulin
tdd
administ
basal
insulin
administ
equal
divid
dose
nutrit
insulin
howev
patient
receiv
steroid
develop
signific
postprandi
hyperglycemia
due
decreas
insulinmedi
glucos
uptak
peripher
tissu
ie
adipos
tissu
skelet
muscl
lead
diabet
expert
suggest
patient
may
need
treat
nutrit
basal
insulin
therefor
hypothes
patient
diabet
treat
steroid
achiev
normoglycemia
hospit
would
higher
nutrit
lower
basal
insulin
requir
achiev
normoglycemia
test
hypothesi
perform
retrospect
studi
noncrit
ill
hospit
patient
diabet
mellitu
receiv
steroid
total
daili
basal
nutrit
correct
insulin
dose
percentag
basal
nutrit
correct
insulin
insulin
tdd
total
daili
insulin
dose
per
kilogram
bodi
weight
unitskg
ratio
insulin
hydrocortison
dose
unitsmg
ratio
insulin
hydrocortison
dose
per
kilogram
unitsmgkg
studi
populationw
identifi
hospit
patient
evalu
inpati
diabet
manag
servic
idm
registri
januari
octob
determin
patient
histori
diabet
receiv
glucocorticoid
n
figur
electron
databas
ie
physician
order
entri
poe
system
electron
patient
record
epr
minim
potenti
nonglucocorticoid
confound
factor
alter
glucos
manag
increas
decreas
insulin
need
exclud
patient
infect
requir
treatment
system
antibiot
n
individu
histori
kidney
failur
glomerular
filtrat
rate
gfr
mlmin
per
liver
failur
intern
normal
ratio
inr
n
human
immunodefici
viru
lipodystrophi
n
patient
receiv
continu
tube
feed
parenter
nutrit
lday
dextros
intraven
iv
fluid
n
also
exclud
patient
receiv
glucocorticoid
hydrocortison
equival
dose
mgday
n
miss
data
n
histori
diabet
mellitu
n
diabet
manag
basalbolu
insulin
regimen
eg
treat
insulin
pump
premix
insulin
oral
medic
n
also
exclud
patient
hypoglycem
event
frequent
hypoglycemia
might
lower
overal
averag
glucos
despit
signific
glucos
fluctuat
n
four
duplic
patient
record
also
exclud
final
patient
sampl
n
includ
patient
eat
receiv
carbohydratecontrol
diet
basalbolu
insulin
regimen
glargineaspart
regimen
n
hospit
carbohydratecontrol
diet
consist
gram
carbohydr
per
tray
studi
approv
institut
review
board
john
hopkin
univers
school
medicin
patient
datafrom
poe
epr
system
collect
demograph
data
age
race
sex
diabet
durat
type
type
type
diabet
mellitu
cystic
fibrosisrel
diabet
post
pancreatectomi
diabet
recent
within
last
month
glycat
hemoglobin
hba
level
medic
comorbid
also
collect
charlson
comorbid
index
score
calcul
also
record
medic
hyperglycem
properti
patient
take
admiss
includ
calcineurin
inhibitor
clonidin
thiazid
atyp
antipsychot
glycemia
assessmentglucos
data
includ
glucos
result
date
time
collect
retrospect
data
collect
sourc
pointofcar
glucos
databas
record
capillari
glucos
measur
epr
record
serum
result
pointofcar
capillari
measur
perform
prior
meal
bedtim
time
daili
nurs
staff
serum
measur
drawn
gener
earli
morn
patient
fast
state
run
central
laboratori
blood
glucos
level
result
record
within
hour
latter
result
exclud
order
avoid
bia
repeat
test
extrem
low
high
blood
glucos
purpos
analysi
normoglycemia
defin
patientdayweight
mean
blood
glucos
pdwmbg
level
mgdl
hyperglycemia
defin
pdwmbg
level
mgdl
record
patient
glucocorticoid
type
dose
daili
insulin
dose
includ
tdd
basal
nutrit
correct
insulin
patient
achiev
achiev
normoglycemia
calcul
follow
variabl
total
daili
basal
nutrit
correct
insulin
dose
total
daili
insulin
dose
per
kilogram
bodi
weight
unitskg
percentag
basal
nutrit
correct
insulin
insulin
tdd
basaltdd
nutrit
tdd
correctiontdd
patient
receiv
differ
type
glucocorticoid
hospit
stay
prednison
methylprednisolon
hydrocortison
dexamethason
differ
dose
convert
glucocorticoid
hydrocortison
equival
allow
compar
glucocorticoid
exposur
group
calcul
insulin
tdd
per
mg
hydrocortison
dose
group
patient
also
calcul
tddhydrocortison
dosekg
potenti
identifi
requir
insulin
dose
hydrocortisonekg
safe
achiev
normoglycemia
bivari
multivari
analys
perform
x
fisher
exact
test
use
compar
categor
covari
test
wilcoxon
rank
sum
test
use
compar
mean
median
continu
covari
respect
natur
logarithm
transform
continu
insulin
dose
measur
necessari
normal
distribut
multivari
linear
model
fit
logtransform
outcom
result
subsequ
back
transform
origin
scale
report
geometr
mean
ci
achiev
achiev
normoglycemia
two
set
multivari
linear
model
specifi
minim
adjust
age
sex
race
fulli
adjust
age
sex
race
diabet
type
diabet
durat
administr
medic
glucosealt
properti
gfr
chronic
kidney
diseas
ckd
stage
modifi
charlson
index
score
covari
remain
model
regardless
statist
signific
consid
potenti
confound
priori
p
valu
use
cutoff
statist
signific
statist
softwar
sa
version
use
analysi
patient
includ
studi
patient
achiev
normoglycemia
admiss
pdwmbg
level
mgdl
patient
remain
hyperglycem
pdwmbg
level
mgdl
p
differ
age
sex
race
bodi
weight
type
durat
diabet
stage
ckd
hba
level
use
medic
hyperglycem
properti
group
tabl
group
receiv
similar
median
dose
glucocorticoid
mgday
mgday
mgday
mgday
achiev
achiev
normoglycemia
respect
p
notabl
howev
group
achiev
normoglycemia
higher
charlson
comorbid
index
score
group
achiev
normoglycemia
vs
tabl
total
daili
basal
insulin
requir
similar
group
tabl
howev
signific
differ
proport
nutrit
correct
insulin
requir
group
compar
patient
achiev
normoglycemia
achiev
normoglycemia
receiv
significantli
higher
total
daili
nutrit
insulin
lower
correct
insulin
tabl
associ
persist
follow
minim
adjust
age
race
sex
multivari
adjust
diabet
type
durat
length
stay
chronic
kidney
diseas
ckd
stage
classif
charlson
comorbid
index
score
use
medic
glucosealt
properti
similarli
patient
achiev
normoglycemia
requir
significantli
lower
percentag
basal
insulin
tdd
correct
insulin
tdd
higher
percentag
nutrit
insulin
tdd
achiev
normoglycemia
tabl
percentag
basaltot
daili
insulin
lower
group
achiev
normoglycemia
compar
hyperglycem
group
although
differ
may
clinic
signific
although
statist
signific
patient
achiev
normoglycemia
requir
slightli
higher
tdd
per
kg
compar
patient
achiev
normoglycemia
tabl
differ
group
ratio
insulin
hydrocortison
dose
ratio
insulin
hydrocortison
per
kg
univari
multivari
analys
tabl
howev
although
statist
signific
ratio
total
daili
insulin
hydrocortison
dose
insulin
hydrocortison
dose
per
kg
higher
normoglycem
group
compar
hyperglycem
group
fulli
adjust
model
studi
show
diabet
andor
hyperglycem
patient
treat
glucocorticoid
achiev
normoglycemia
requir
nutrit
less
correct
insulin
rel
tdd
compar
patient
achiev
normoglycemia
also
trend
toward
higher
total
daili
insulin
dose
per
kg
patient
achiev
normoglycemia
compar
although
differ
statist
signific
multivari
model
hyperglycemia
repres
import
frequent
side
effect
patient
receiv
glucocorticoid
although
glucocorticoid
repres
one
common
medic
prescrib
outpati
inpati
set
littl
data
support
clinic
practic
recommend
individu
without
diabet
develop
signific
hyperglycemia
recent
publish
guidelin
recommend
patient
treat
glucocorticoid
receiv
start
total
daili
insulin
dose
unitskg
day
reason
initi
therapi
conserv
insulin
regimen
howev
knowledg
studi
perform
order
identifi
target
tdd
insulin
requir
achiev
normoglycemia
patient
diabet
receiv
steroid
data
indic
patient
achiev
normglycemia
requir
much
higher
insulin
dose
close
unitskgday
find
higher
nutrit
insulin
requir
patient
receiv
glucocorticoid
achiev
glycem
target
also
consist
expert
opinion
recommend
howev
recommend
base
clinic
observ
rather
clinic
research
studi
recent
publish
guidelin
specif
comment
potenti
increas
nutrit
insulin
need
patient
receiv
glucocorticoid
recommend
iv
insulin
infus
basalbolu
approach
effect
although
iv
insulin
infus
treatment
like
safest
effici
approach
achiev
normoglycemia
patient
method
may
feasibl
nonicu
noncrit
care
set
eg
gener
ward
necessit
develop
altern
approach
achiev
glycem
target
use
subcutan
insulin
studi
glargin
basal
insulin
use
insulin
regimen
use
neutral
protamin
hagedorn
nph
suggest
altern
approach
intreat
glucocorticoidinduc
hyperglycemia
patient
without
histori
diabet
mellitu
especi
particular
patient
receiv
prednison
prednisolon
nph
prednison
prednisolon
share
similar
pharmacodynam
properti
review
articl
also
suggest
approach
adjust
nph
dose
set
glucocorticoid
taper
acknowledg
limit
approach
author
state
regimen
appli
patient
receiv
longact
glucocorticoid
dexamethason
longeract
insulin
glargin
detemir
may
effect
recent
studi
show
administr
nph
glargin
basal
insulin
equal
effect
treat
patient
prednisoneinduc
hyperglycemia
seggelk
et
al
perform
small
studi
patient
cystic
fibrosi
receiv
methylprednisolon
assess
glucos
outcom
patient
treat
glargin
lispro
compar
glargin
lispro
nph
result
show
treatment
group
similar
normoglycem
fast
blood
glucos
level
howev
group
receiv
nph
addit
basalbolu
regimen
better
prelunch
predinn
glucos
level
studi
limit
small
number
patient
n
short
studi
durat
day
inclus
patient
cystic
fibrosi
limit
generaliz
find
addit
control
group
receiv
similar
amount
glargin
lispro
insulin
close
unknown
would
achiev
better
postprandi
glycem
control
higher
dose
nutrit
insulin
earli
studi
result
suggest
comb
nph
insulin
multipl
daili
inject
regimen
oncedaili
basal
insulin
rapidact
analog
may
effect
treat
glucocorticoidinduc
hyperglycemia
howev
although
report
use
differ
insulin
type
could
potenti
lead
medic
error
deleteri
effect
patient
altern
approach
increas
proport
total
daili
insulin
dose
administ
nutrit
insulin
better
treat
postprandi
hyperglycemia
associ
glucocorticoid
administr
data
suggest
higher
dose
nutrit
insulin
may
effect
achiev
glycem
target
patient
glucocorticoidinduc
hyperglycemia
approxim
total
daili
insulin
dose
administ
basal
insulin
administ
nutrit
insulin
approach
treat
postprandi
hyperglycemia
higher
dose
nutrit
insulin
set
glucocorticoid
administr
physiolog
rational
glucocorticoid
induc
insulin
resist
therefor
exacerb
postprandi
hyperglycemia
differ
pathway
affect
either
muscl
adipos
tissu
liver
bone
rat
skelet
muscl
cell
dexamethason
treatment
decreas
express
key
element
insulin
receptor
pathway
insulin
receptor
substrat
ir
phospatidylinositol
kinas
protein
kinas
b
pkb
steroid
administr
rat
also
shown
decreas
migrat
glucos
transport
surfac
muscl
glucocorticoid
also
induc
muscl
skelet
atrophi
increas
protein
degrad
releas
amino
acid
shown
alter
insulin
signal
inhibit
phosphoryl
activ
adipos
tissu
glucocorticoid
shown
downregul
adipocyt
also
alter
express
sever
adipokin
adiponectin
resistin
final
liver
glucocorticoid
induc
insulin
resist
differ
mechan
administr
glucocorticoid
induc
hepat
insulin
resist
impair
insulin
suppress
effect
hepat
glucos
product
especi
postprandi
state
demonstr
healthi
subject
follow
shortterm
glucocorticoid
exposur
recent
report
longterm
treatment
glucocorticoid
induc
insulin
resist
suppress
osteoblastderiv
peptid
osteocalcin
studi
sever
limit
kept
mind
interpret
data
first
sampl
size
small
patient
consult
consid
patient
receiv
steroid
patient
signific
comorbid
prevent
includ
rational
tri
avoid
comorbid
unrel
glucocorticoid
could
significantli
alter
patient
insulin
requir
consequ
may
select
bia
result
generaliz
noncrit
care
set
patient
greater
sever
ill
second
notabl
group
patient
achiev
normoglycemia
higher
modifi
charlson
comorbid
index
score
compar
patient
group
achiev
normoglycemia
therefor
exclud
possibl
provid
care
patient
may
perceiv
higher
risk
hospitalrel
complic
may
treat
aggress
result
better
glycem
control
third
studi
retrospect
may
complet
case
ascertain
unabl
implement
specif
insulinmanag
strategi
examin
effect
prospect
fourth
patient
preexist
diabet
find
may
differ
individu
without
preexist
diabet
isol
glucocorticoidinduc
hyperglycemia
fifth
analysi
includ
patient
order
carbohydratecontrol
diet
unfortun
data
regard
total
calor
intak
amount
carbohydr
actual
consum
may
impact
anorexia
nausea
vomit
diarrhea
hospit
set
final
retrospect
natur
studi
may
residu
confound
may
influenc
bias
result
summari
data
suggest
noncrit
ill
patient
hyperglycemia
receiv
steroid
requir
higher
percentag
insulin
tdd
nutrit
insulin
achiev
normoglycemia
futur
clinic
trial
examin
approach
use
basalbolu
insulin
ratio
compar
standard
basalbolu
ratio
use
insulin
nph
compar
effect
among
treatment
reach
glycem
target
patient
studi
would
fill
import
research
gap
recent
identifi
plan
research
inpati
diabet
pride
investig
recent
overview
gap
current
knowledg
deliv
highqual
inpati
care
patient
diabet
hyperglycemia
flow
diagram
select
studi
popul
abbrevi
ckd
chronic
kidney
diseas
gfr
glomerular
filtrat
rate
ivf
dextros
intraven
iv
fluid
type
diabet
cystic
fibrosisrel
diabet
postpancreatectomi
diabet
abbrevi
ckd
chronic
kidney
diseas
gfr
glomerular
filtrat
rate
pdwmb
patientday
weight
mean
blood
sd
standard
deviat
hosp
pract
author
manuscript
avail
pmc
juli
